Literature DB >> 9714296

Kinetic effects due to nonspecific substrate-inhibitor interactions in enzymatic reactions.

R A Copeland1, K Y Horiuchi.   

Abstract

Nonspecific protein binding is a commonly encountered problem with synthetic molecules designed as enzyme inhibitors. When the substrate for the enzymatic reaction is itself a protein, such nonspecific protein binding can also occur. Here, we demonstrate that this phenomenon can have a dramatic effect on the steady-state kinetic evaluation of such inhibitors.

Mesh:

Substances:

Year:  1998        PMID: 9714296     DOI: 10.1016/s0006-2952(97)00663-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Mechanism and specificity of a symmetrical benzimidazolephenylcarboxamide helicase inhibitor.

Authors:  Craig A Belon; Yoji D High; Tse-I Lin; Frederik Pauwels; David N Frick
Journal:  Biochemistry       Date:  2010-03-09       Impact factor: 3.162

2.  Selective non-nucleoside inhibitors of human DNA methyltransferases active in cancer including in cancer stem cells.

Authors:  Sergio Valente; Yiwei Liu; Michael Schnekenburger; Clemens Zwergel; Sandro Cosconati; Christina Gros; Maria Tardugno; Donatella Labella; Cristina Florean; Steven Minden; Hideharu Hashimoto; Yanqi Chang; Xing Zhang; Gilbert Kirsch; Ettore Novellino; Paola B Arimondo; Evelina Miele; Elisabetta Ferretti; Alberto Gulino; Marc Diederich; Xiaodong Cheng; Antonello Mai
Journal:  J Med Chem       Date:  2014-01-15       Impact factor: 7.446

3.  New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.

Authors:  Christina Gros; Laurence Fleury; Virginie Nahoum; Céline Faux; Sergio Valente; Donatella Labella; Frédéric Cantagrel; Elodie Rilova; Mohamed Amine Bouhlel; Marie-Hélène David-Cordonnier; Isabelle Dufau; Frédéric Ausseil; Antonello Mai; Lionel Mourey; Laurent Lacroix; Paola B Arimondo
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

4.  Assessment of Metabolic Interaction between Repaglinide and Quercetin via Mixed Inhibition in the Liver: In Vitro and In Vivo.

Authors:  Ji-Min Kim; Seong-Wook Seo; Dong-Gyun Han; Hwayoung Yun; In-Soo Yoon
Journal:  Pharmaceutics       Date:  2021-05-23       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.